These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7895897)

  • 41. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
    Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
    Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
    [No Abstract]   [Full Text] [Related]  

  • 42. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
    Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
    Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
    Hummel J; Westphal S; Weber-Hamann B; Gilles M; Lederbogen F; Angermeier T; Luley C; Deuschle M; Kopf D
    J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbuminuria.
    Dullaart RP; Dikkeschei LD; Doorenbos H
    Diabetologia; 1989 Sep; 32(9):685-9. PubMed ID: 2507381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The long-term effects of rosiglitazone on serum lipid concentrations and body weight.
    Shim WS; Do MY; Kim SK; Kim HJ; Hur KY; Kang ES; Ahn CW; Lim SK; Lee HC; Cha BS
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):453-9. PubMed ID: 16984237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dietary fructose as a natural sweetener in poorly controlled type 2 diabetes: a 12-month crossover study of effects on glucose, lipoprotein and apolipoprotein metabolism.
    Osei K; Bossetti B
    Diabet Med; 1989 Aug; 6(6):506-11. PubMed ID: 2527132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of temocapril hydrochloride on serum lipid levels in patients with hypertensive type 2 diabetes mellitus.
    Miyashita Y; Ito Y; Hasiguchi S; Totsuka M; Aoki A; Kurokawa M; Tomioka H; Shirai K
    J Atheroscler Thromb; 2001; 8(1):25-9. PubMed ID: 11686312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cholesterol-lowering therapy may retard the progression of diabetic nephropathy.
    Lam KS; Cheng IK; Janus ED; Pang RW
    Diabetologia; 1995 May; 38(5):604-9. PubMed ID: 7489845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy.
    Eirís J; Novo-Rodríguez MI; Del Río M; Meseguer P; Del Río MC; Castro-Gago M
    Epilepsy Res; 2000 Aug; 41(1):1-7. PubMed ID: 10924863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Effect of Vitamin D Supplementation on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes Mellitus.
    Mohamad MI; El-Sherbeny EE; Bekhet MM
    J Am Coll Nutr; 2016 Jul; 35(5):399-404. PubMed ID: 26391639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia.
    Anderson JW; Allgood LD; Turner J; Oeltgen PR; Daggy BP
    Am J Clin Nutr; 1999 Oct; 70(4):466-73. PubMed ID: 10500014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical efficacy of pravastatin for hyperlipidemia in patients with type 2 diabetes mellitus.
    Tawata M; Miwa I; Tsuchiya K; Ozawa M; Shindo H; Wakasugi M; Onaya T
    Arzneimittelforschung; 1995 Jun; 45(6):704-8. PubMed ID: 7646575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.
    Rigoli L; Raimondo G; Di Benedetto A; Romano G; Porcellini A; Campo S; Corica F; Riccardi G; Squadrito G; Cucinotta D
    Acta Diabetol; 1995 Dec; 32(4):251-6. PubMed ID: 8750764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein B in type 2 diabetics--a cross sectional study in a tertiary care set-up.
    Kanani FH; Alam JM
    J Pak Med Assoc; 2010 Aug; 60(8):653-6. PubMed ID: 20726197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.
    Kastelein JJ; van der Steeg WA; Holme I; Gaffney M; Cater NB; Barter P; Deedwania P; Olsson AG; Boekholdt SM; Demicco DA; Szarek M; LaRosa JC; Pedersen TR; Grundy SM; ;
    Circulation; 2008 Jun; 117(23):3002-9. PubMed ID: 18519851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dietary advice and lipid metabolism in insulin-dependent diabetes mellitus kidney- and pancreas-transplanted patients.
    La Rocca E; Ruotolo G; Parlavecchia M; Librenti MC; Secchi A; Caldara R; Bonfatti D; Bernardi M; Di Carlo V; Pozza G
    Transplant Proc; 1992 Jun; 24(3):848-9. PubMed ID: 1604637
    [No Abstract]   [Full Text] [Related]  

  • 58. Lipoprotein abnormalities in insulin-dependent diabetes mellitus.
    Winocour PH; Durrington PN; Ishola M; Anderson DC
    Lancet; 1986 May; 1(8491):1176-8. PubMed ID: 2871420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationships of apolipoprotein B(100) with the metabolic syndrome in Type 2 diabetes mellitus.
    Relimpio F; Losada F; Pumar A; Mangas MA; Morales F; Astorga R
    Diabetes Res Clin Pract; 2002 Sep; 57(3):199-207. PubMed ID: 12126770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The transport of vitamin E in plasma and its correlation to plasma lipoproteins in non-insulin-dependent diabetes mellitus.
    Kökoğlu E; Ulakoğlu E
    Diabetes Res Clin Pract; 1991 Dec; 14(3):175-81. PubMed ID: 1778110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.